Crossmark

Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers

Crossref DOI link: https://doi.org/10.1007/s00520-024-08868-7

Published Online: 2024-09-24

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Falade, Ayo S.

Boulanger, Mary C.

Hsu, Kelly

Sarathy, Roshni

Fadden, Riley

Reynolds, Kerry L.

Traeger, Lara

Temel, Jennifer S.

Greer, Joseph A.

Petrillo, Laura A.
Funding

Funding for this research was provided by:

American Cancer Society (Clinical Research Professor)

Conquer Cancer Foundation (Career Development Award)

Division of Cancer Prevention, National Cancer Institute (K08CA263549)
License Information

Text and Data Mining valid from 2024-09-24

Version of Record valid from 2024-09-24
More Information

Article History

Received: 13 June 2024

Accepted: 9 September 2024

First Online: 24 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below